{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:13:33Z","timestamp":1785428013301,"version":"3.56.0"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Oxygen-enhanced MRI (OE-MRI) has shown promise for quantifying and spatially mapping tumor hypoxia, either alone or in combination with perfusion imaging. Previous studies have validated the technique in mouse models and in patients with cancer. Here, we report the first evidence that OE-MRI can track change in tumor oxygenation induced by two drugs designed to modify hypoxia. Mechanism of action of banoxantrone and atovaquone were confirmed using in vitro experiments. Next, in vivo OE-MRI studies were performed in Calu6 and U87 xenograft tumor models, alongside fluorine-18\u2013fluoroazomycin arabinoside PET and immunohistochemistry assays of hypoxia. Neither drug altered tumor size. Banoxantrone reduced OE-MRI hypoxic fraction in Calu6 tumors by 52.5% \u00b1 12.0% (P = 0.008) and in U87 tumors by 29.0% \u00b1 15.8% (P = 0.004) after 3 days treatment. Atovaquone reduced OE-MRI hypoxic fraction in Calu6 tumors by 53.4% \u00b1 15.3% (P = 0.002) after 7 days therapy. PET and immunohistochemistry provided independent validation of the MRI findings. Finally, combined OE-MRI and perfusion imaging showed that hypoxic tissue was converted into necrotic tissue when treated by the hypoxia-activated cytotoxic prodrug banoxantrone, whereas hypoxic tissue became normoxic when treated by atovaquone, an inhibitor of mitochondrial complex III of the electron transport chain. OE-MRI detected and quantified hypoxia reduction induced by two hypoxia-modifying therapies and could distinguish between their differential mechanisms of action. These data support clinical translation of OE-MRI biomarkers in clinical trials of hypoxia-modifying agents to identify patients demonstrating biological response and to optimize treatment timing and scheduling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>For the first time, we show that hypoxic fraction measured by oxygen-enhanced MRI (OE-MRI) detected changes in tumor oxygenation induced by two drugs designed specifically to modify hypoxia. Furthermore, when combined with perfusion imaging, OE-MRI hypoxic volume distinguished the two drug mechanisms of action. This imaging technology has potential to facilitate drug development, enrich clinical trial design, and accelerate clinical translation of novel therapeutics into clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0315","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:50:29Z","timestamp":1725612629000},"page":"2565-2574","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-8497","authenticated-orcid":false,"given":"James P.B.","family":"O\u2019Connor","sequence":"first","affiliation":[{"name":"Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom. 1"},{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. 2"},{"name":"Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-814X","authenticated-orcid":false,"given":"Victoria","family":"Tessyman","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Optometry, University of Manchester, Manchester, United Kingdom. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6933-4883","authenticated-orcid":false,"given":"Ross A.","family":"Little","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0717-0149","authenticated-orcid":false,"given":"Muhammad","family":"Babur","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Optometry, University of Manchester, Manchester, United Kingdom. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-5988","authenticated-orcid":false,"given":"Duncan","family":"Forster","sequence":"additional","affiliation":[{"name":"Cancer Research UK Manchester Centre, University of Manchester, Manchester, United Kingdom. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7245-8729","authenticated-orcid":false,"given":"Ay\u015fe","family":"Latif","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Optometry, University of Manchester, Manchester, United Kingdom. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9024-8980","authenticated-orcid":false,"given":"Susan","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2899-580X","authenticated-orcid":false,"given":"Grazyna","family":"Lipowska-Bhalla","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-909X","authenticated-orcid":false,"given":"Geoff S.","family":"Higgins","sequence":"additional","affiliation":[{"name":"CRUK\/MRC Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-6358","authenticated-orcid":false,"given":"Marie-Claude","family":"Asselin","sequence":"additional","affiliation":[{"name":"Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, United Kingdom. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-2234","authenticated-orcid":false,"given":"Geoff J.M.","family":"Parker","sequence":"additional","affiliation":[{"name":"Bioxydyn Ltd., Manchester, United Kingdom. 8"},{"name":"Centre for Medical Image Computing, University College London, London, United Kingdom. 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-3770","authenticated-orcid":false,"given":"Kaye J.","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Optometry, University of Manchester, Manchester, United Kingdom. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"2026031614515649600_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2026031614515649600_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031614515649600_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"2026031614515649600_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.radonc.2017.08.010","article-title":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","volume":"124","author":"L\u00f6ck","year":"2017","journal-title":"Radiother Oncol"},{"key":"2026031614515649600_bib5","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026031614515649600_bib6","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J Clin Invest"},{"key":"2026031614515649600_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1470-2045(02)00929-4","article-title":"ARCON: a novel biology-based approach in radiotherapy","volume":"3","author":"Kaanders","year":"2002","journal-title":"Lancet Oncol"},{"key":"2026031614515649600_bib8","doi-asserted-by":"crossref","first-page":"20170843","DOI":"10.1259\/bjr.20170843","article-title":"Targeting tumour hypoxia: shifting focus from oxygen supply to demand","volume":"92","author":"Coates","year":"2019","journal-title":"Br J Radiol"},{"key":"2026031614515649600_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5\u201385","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"2026031614515649600_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clon.2014.02.002","article-title":"The meaning, measurement and modification of hypoxia in the laboratory and the clinic","volume":"26","author":"Hammond","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026031614515649600_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djx160","article-title":"Targeting hypoxia to improve non\u2013small cell lung cancer outcome","volume":"110","author":"Salem","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2026031614515649600_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","article-title":"Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene","volume":"102","author":"Buffa","year":"2010","journal-title":"Br J Cancer"},{"key":"2026031614515649600_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"H\u00f6ckel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2026031614515649600_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/09553000601002324","article-title":"Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy","volume":"82","author":"Tatum","year":"2006","journal-title":"Int J Radiat Biol"},{"key":"2026031614515649600_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"2026031614515649600_bib16","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/1078-0432.CCR-15-0018","article-title":"TH-302 in combination with radiotherapy enhances the therapeutic outcome and is associated with pretreatment [18F]HX4 hypoxia PET imaging","volume":"21","author":"Peeters","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026031614515649600_bib17","doi-asserted-by":"crossref","first-page":"S4007","DOI":"10.1200\/JCO.2016.34.15_suppl.4007","article-title":"MAESTRO: a randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)","volume":"34","author":"Van Cutsem","year":"2016","journal-title":"J Clin Oncol"},{"key":"2026031614515649600_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0149-936X(81)90089-8","article-title":"Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging","volume":"5","author":"Young","year":"1981","journal-title":"J Comput Tomogr"},{"key":"2026031614515649600_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-15-2818","article-title":"Oxygen-enhanced MRI is a major advance in tumor hypoxia imaging","volume":"76","author":"Dewhirst","year":"2016","journal-title":"Cancer Res"},{"key":"2026031614515649600_bib20","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/mrm.24826","article-title":"Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma","volume":"71","author":"Linnik","year":"2014","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/0008-5472.CAN-15-2062","article-title":"Oxygen-enhanced MRI accurately identifies, quantifies, and maps tumor hypoxia in preclinical cancer models","volume":"76","author":"O\u2019Connor","year":"2016","journal-title":"Cancer Res"},{"key":"2026031614515649600_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiol.2018171531","article-title":"Mapping hypoxia in renal carcinoma with oxygen-enhanced MRI: comparison with intrinsic susceptibility MRI and pathology","volume":"288","author":"Little","year":"2018","journal-title":"Radiology"},{"key":"2026031614515649600_bib23","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-18-3932","article-title":"Oxygen-enhanced MRI is feasible, repeatable and detects radiotherapy-induced change in hypoxia in xenograft models and in patients with non-small cell lung cancer","volume":"25","author":"Salem","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026031614515649600_bib24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1054\/bjoc.2000.1564","article-title":"AQ4N: a new approach to hypoxia-activated cancer chemotherapy","volume":"83","author":"Patterson","year":"2000","journal-title":"Br J Cancer"},{"key":"2026031614515649600_bib25","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat Commun"},{"key":"2026031614515649600_bib26","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-20-4128","article-title":"Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer","volume":"27","author":"Skwarski","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2026031614515649600_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","article-title":"Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome","volume":"21","author":"O\u2019Connor","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026031614515649600_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41416-019-0627-y","article-title":"Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin","volume":"122","author":"Sivalingam","year":"2020","journal-title":"Br J Cancer"},{"key":"2026031614515649600_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"Guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman","year":"2010","journal-title":"Br J Cancer"},{"key":"2026031614515649600_bib30","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1158\/1535-7163.MCT-09-0396","article-title":"In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts","volume":"8","author":"Williams","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2026031614515649600_bib31","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1158\/1078-0432.CCR-06-2427","article-title":"Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer","volume":"13","author":"Lalani","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026031614515649600_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1535-7163.MCT-12-0905","article-title":"[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941","volume":"12","author":"Cawthorne","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2026031614515649600_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6605753","article-title":"The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy","volume":"103","author":"Lunt","year":"2010","journal-title":"Br J Cancer"},{"key":"2026031614515649600_bib34","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2967\/jnumed.112.116293","article-title":"18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model","volume":"54","author":"Chitneni","year":"2013","journal-title":"J Nucl Med"},{"key":"2026031614515649600_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mrm.21470","article-title":"Quantification of viable tumor microvascular characteristics by multispectral analysis","volume":"60","author":"Berry","year":"2008","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.media.2016.06.012","article-title":"Oncological image analysis","volume":"33","author":"Brady","year":"2016","journal-title":"Med Image Anal"},{"key":"2026031614515649600_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1196-1236","article-title":"Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging","volume":"2","author":"Edelman","year":"1996","journal-title":"Nat Med"},{"key":"2026031614515649600_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mrm.21357","article-title":"Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times","volume":"58","author":"O\u2019Connor","year":"2007","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/mrm.20961","article-title":"MR assessment of changes of tumor in response to hyperbaric oxygen treatment","volume":"56","author":"Matsumoto","year":"2006","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1088\/0031-9155\/56\/5\/001","article-title":"Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia","volume":"56","author":"Winter","year":"2011","journal-title":"Phys Med Biol"},{"key":"2026031614515649600_bib41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mrm.24511","article-title":"Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation","volume":"70","author":"Jordan","year":"2013","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jmri.23987","article-title":"Exploring \u0394R2* and \u0394R1 as imaging biomarkers of tumor oxygenation","volume":"38","author":"Burrell","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"2026031614515649600_bib43","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/mrm.25821","article-title":"O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models","volume":"75","author":"Beeman","year":"2016","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2016.06.003","article-title":"Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response","volume":"380","author":"White","year":"2016","journal-title":"Cancer Lett"},{"key":"2026031614515649600_bib45","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/mrm.27584","article-title":"Fast and sensitive dynamic oxygen-enhanced MRI with a cycling gas challenge and independent component analysis","volume":"81","author":"Moosvi","year":"2019","journal-title":"Magn Reson Med"},{"key":"2026031614515649600_bib46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jmri.25051","article-title":"Feasibility and reproducibility of BOLD and TOLD measurements in the liver with oxygen and carbogen gas challenge in healthy volunteers and patients with hepatocellular carcinoma","volume":"43","author":"Bane","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"2026031614515649600_bib47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ijrobp.2008.12.040","article-title":"Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors","volume":"75","author":"O\u2019Connor","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031614515649600_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","article-title":"Imaging biomarker roadmap for cancer studies","volume":"14","author":"O\u2019Connor","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2026031614515649600_bib49","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1158\/0008-5472.CAN-19-0213","article-title":"Multiparametric MRI and co-registered histology identify tumor habitats in breast cancer mouse models","volume":"79","author":"Jardim-Perassi","year":"2019","journal-title":"Cancer Res"},{"key":"2026031614515649600_bib50","first-page":"156","article-title":"Examining correlations of oxygen sensitive MRI (BOLD\/TOLD) with [18F]FMISO PET in rat prostate tumors","volume":"9","author":"Zhou","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2026031614515649600_bib51","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026031614515649600_bib52","first-page":"OF1","article-title":"Oxygen-enhanced MRI detects incidence, onset and heterogeneity of radiation-induced hypoxia modification in HPV-associated oropharyngeal cancer","author":"Dubec","year":"2024","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0315\/3494263\/crc-24-0315.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/10\/2565\/3502743\/crc-24-0315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/10\/2565\/3502743\/crc-24-0315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:52:08Z","timestamp":1773687128000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/10\/2565\/748751\/Combined-Oxygen-Enhanced-MRI-and-Perfusion-Imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0315","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.27144158","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144128","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727816","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144146","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727810","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762228","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144140","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762216","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727822","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762222","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762210","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727807","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144137","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144149","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727819","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727813","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144155","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762231","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27144131","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762225","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7474811","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}